Market Tracker

07/22 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date
Valeant Hits Another Bump
Jul 22 / TheStreet.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment
Jul 22 / TheStreet.com - Paid Partner Content
Valeant's Drug Approvals May Save the Day
Jul 20 / TheStreet.com - Paid Partner Content
Valeant Drug Approval Hampered by FDA Facility Inspection
Jul 22 / TheStreet.com - Paid Partner Content
Jim Cramer -- Valeant Needs These New Drug Approvals
Jul 20 / TheStreet.com - Paid Partner Content
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug
Jul 20 / TheStreet.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close24.48
Today’s open24.20
Day’s range22.72 - 24.30
Volume23,491,879
Average volume (3 months)34,462,647
Market cap$7.8B
Dividend yield--
Data as of 4:00pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-34.74%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.83+1.69%
MNKMallinckrodt Plc-1.04-1.54%
IDXXIDEXX Laboratories I...+0.18+0.19%
JAZZJazz Pharmaceuticals...-1.58-1.10%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$1.57
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Senior VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts